The actin and microtubule network regulator WHAMM is identified as a key kidney disease risk gene
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.115462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Dhanunjay Mukhi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA; Department of Genetics, University of Pennsylvania, P…. Hauptthemen laut MEDLINE: Actins, Microtubules, Kidney Diseases, Genetic Predisposition to Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Nearly 850 million people suffer from kidney disease worldwide. Genome-wide association studies identify genetic variations at more than 800 loci associated with kidney dysfunction; however, the target genes, cell types, and mechanisms remain poorly understood. Here, we show that nucleotide variants on chromosome 15 are not only associated with kidney dysfunction but also regulate the expression of Wasp homolog associated with actin, membranes, and microtubules (WHAMM). WHAMM expression is higher in mice and patients with chronic and acute kidney disease. Mice with genetic deletion of Whamm appear healthy at baseline but develop less injury following cisplatin, folic acid, and unilateral ureteral obstruction. In vitro cell studies indicate that WHAMM controls cell death by regulating actin-mediated cytochrome c release from mitochondria and the formation of ASC speck. Pharmacological inhibition of actin dynamics mitigates kidney disease in experimental models. In summary, our study identifies a key role of WHAMM in the development of kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA; Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA; Penn/CHOP Kidney Innovation Center, University o…
- Department of Biomedical Genetics, University of Rochester, Rochester, NY, USA.
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Mukhi, D., Kolligundla, L. P., Doke, T., Silva, M. A., Liu, H., Palmer, M., & Susztak, K. (2025). The actin and microtubule network regulator WHAMM is identified as a key kidney disease risk gene. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115462
Vancouver
Mukhi D, Kolligundla LP, Doke T, Silva MA, Liu H, Palmer M, et al. The actin and microtubule network regulator WHAMM is identified as a key kidney disease risk gene. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115462
BibTeX
@article{Mukhi2025,
author = {Mukhi, Dhanunjay and Kolligundla, Lakshmi Prasanna and Doke, Tomohito and Silva, Magaiver Andrade- and Liu, Hongbo and Palmer, Matthew and Susztak, Katalin},
title = {The actin and microtubule network regulator WHAMM is identified as a key kidney disease risk gene},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.115462}
}
EUVIMED